ARCHIVES

DCPC Faces Huge Out Year Costs Of Four Trials

This article is from The Cancer Letter archive.

Vol. 17 No. 07 | February 15, 1991

Download PDF Visit The Full Archive

Related Articles

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

December 31, 2010

NCI Cooperative Group Clinical Trials Approved

August 28, 2009

Surgical Oncology Planners Develop NCPP research Approaches, Projects

May 24, 1974

Congress Approves Payments For Treatment Of Women Diagnosed In CDC Program.

October 13, 2000

FDA’s Handling Of UFT Raises Questions About Agency’s Isolation, Grasp Of Science.

July 21, 2000